Related Experiment Video
Updated: Jul 3, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Argyria attributed to silvadene application in a patient with dystrophic epidermolysis bullosa
John C Browning1, Moise L Levy
1Department of Dermatology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA. johnbrowningmd@yahoo.com
Abstract:
Argyria is most commonly reported in association with prolonged ingestion of silver-containing medicaments. This case illustrates the rather unique case of development of argyria following application of silver sulfadiazine in a patient with epidermolysis bullosa.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Staphylococcal Skin Infections
Formation of Complex Ions
